NCT07888556
Exploring Curative Model for Advanced Breast Cancer: a Single-center, Prospective Phase II Clinical Study
StatusNot Yet Recruiting
PhaseNot specified
SponsorHenan Cancer Hospital
Primary completion (estimated)
Track this trial
Free. We email you which fields changed when ClinicalTrials.gov updates this record.
Record History
All 1 version: 1 with changes below.
- Study First Submitted
Endpoints
Primary
3-year PFS rate after treatment discontinuation
Timeframe: 3 years after treatment discontinuation
Secondary (4)
1-year PFS rate after treatment discontinuation
5-year PFS rate after treatment discontinuation
OS
QOL
Arms and interventions
Cohort A
Continue the original anti-tumor treatment regimen for 1 year
Cohort B
Continue the original anti-tumor treatment regimen for 2 years
Cohort C
Continue the original anti-tumor treatment regimen for 3 years
Sites
1 site in 1 country
- Henan Breast Cancer Center, The Affiliated Cancer Hospital of Zhengzhou UniversityZhengzhou, Henan, China